GlassScriptPhysician profile
Samuel Lynch
NPI 1649972431
$2,169.11
in general payments reported to CMS, 2019-2025
16 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $728 · 2024: $1,147 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,169.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $622.89 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $531.61 | 2024-2025 | |
| Neurocrine Biosciences, INC. | $214.00 | 2024 | Ingrezza |
| Glaxosmithkline, LLC. | $174.14 | 2023 | Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $144.06 | 2025 | Caplyta |
| Idorsia Pharmaceuticals US INC | $141.51 | 2023 | Quviviq |
| Astellas Pharma US INC | $116.02 | 2024 | Veozah |
| Lilly USA, LLC | $38.97 | 2023 | Jardiance, Emgality |
| Pfizer INC. | $38.03 | 2024 | |
| Exact Sciences Corporation | $36.17 | 2025 | Cologuard Collection Kit |
| Sumitomo Pharma America, INC. | $28.60 | 2023 | Gemtesa |
| Vertos Medical, INC. | $18.81 | 2023 | Mild Device Kit |
| Impulse Dynamics (USA) INC. | $17.60 | 2024 | Optimizer |
| Actelion Pharmaceuticals US, INC. | $16.06 | 2023 | Opsumit |
| Xeris Pharmaceuticals, INC. | $15.61 | 2023 | Gvoke Hypopen |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $15.03 | 2023 | Ozempic, Rybelsus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samuel Lynch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.